[Development Status of Irreversible Electric Perforated Tumor Ablation Device]

Tianshuai He; Kun Tan; Qianqian Sun; Zhirui Zhang; Xue Chen; Yi Lyu; Rongqian Wu

doi:10.3969/j.issn.1671-7104.2021.06.014

[Development Status of Irreversible Electric Perforated Tumor Ablation Device]

Zhongguo Yi Liao Qi Xie Za Zhi. 2021 Nov 30;45(6):655-661. doi: 10.3969/j.issn.1671-7104.2021.06.014.

[Article in Chinese]

Authors

Tianshuai He^{1

2}, Kun Tan³, Qianqian Sun³, Zhirui Zhang³, Xue Chen^{1

2}, Yi Lyu^{1

2}, Rongqian Wu^{1

2}

Affiliations

¹ National Local Joint Engineering Research Center for Precision Surgery and Regenerative Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061.
² Regenerative Medicine and Surgical Engineering Research Center of Shaanxi Province, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061.
³ Health Science Center, Xi'an Jiaotong University, Xi'an, 710061.

PMID: 34862780
DOI: 10.3969/j.issn.1671-7104.2021.06.014

Abstract

This study firstly introduced the mechanism, benefits and applications of irreversible electroporation(IRE) for tumor ablation. In addition, this study also introduced the most advanced IRE systems cleared by FDA or CFDA and IRE research equipment. The clinically licensed IRE systems include the Nanoknife 3.0 of Angiodynamics, the Dophi^TM N3000's steep pulse therapy system of Sanoway, and compound steep pulse therapy equipment of Reeves Technology IRE research equipment include the BTX and Bio-Rad electroporation devices.

Keywords: electroporation devices; irreversible electroporation; tumor ablation.

MeSH terms

Electricity
Electroporation*
Heart Rate
Humans
Neoplasms* / therapy